【潮热治疗药物ABCL635中期试验取得积极结果 AbCellera Biologics(ABCL.US)应声大涨】智通财经APP获悉,加拿大生物科技公司AbCellera
Biologics(ABCL.US)股价周一收涨近35%,盘中一度上涨逾44%。该公司表示,其一款用于治疗潮热症状的潜在药物在中期临床试验中达到主要终点,显示出有效性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.